Heliyon,
Год журнала:
2023,
Номер
10(1), С. e23659 - e23659
Опубликована: Дек. 12, 2023
Sphingolipid
metabolism
affects
prognosis
and
resistance
to
immunotherapy
in
patients
with
cancer
is
an
emerging
target
therapy
promising
diagnostic
prognostic
value.
Long
noncoding
ribonucleic
acids
(lncRNAs)
broadly
regulate
tumour-associated
metabolic
reprogramming.
However,
the
potential
of
sphingolipid
metabolism-related
lncRNAs
pancreatic
adenocarcinoma
(PAAD)
poorly
understood.
In
this
study,
coexpression
algorithms
were
employed
identify
lncRNAs.
The
least
absolute
shrinkage
selection
operator
(LASSO)
algorithm
was
used
develop
a
lncRNA
signature
(SMLs).
predictive
stability
SMLs
validated
using
Kaplan-Meier.
Univariate
multivariate
Cox,
receiver
operating
characteristic
(ROC)
clinical
stratification
analyses
comprehensively
assess
SMLs.
Gene
set
variation
analysis
(GSVE),
gene
ontology
(GO)
tumor
mutation
burden
(TMB)
explored
mechanisms.
Additionally,
single
sample
enrichment
(ssGSEA),
ESTIMATE,
immune
checkpoints
drug
sensitivity
investigate
function
Finally,
SMLs-based
consensus
clustering
utilized
differentiate
determine
suitable
population
for
immunotherapy.
results
showed
that
consists
seven
lncRNAs,
which
can
well
outcome
individuals
PAAD,
high
general
applicability.
addition,
divided
TCGA-PAAD
cohort
into
two
clusters,
Cluster
1
showing
better
survival
than
2.
had
higher
level
cell
infiltration
2,
combined
levels
suggests
more
consistent
'hot
tumor'
profile
may
respond
checkpoint
inhibitors
(ICIs).
This
study
offers
new
insights
regarding
role
as
biomarkers
PAAD.
constructed
are
valuable
tools
predicting
outcomes
PAAD
provide
basis
individualized
treatments.
Background:
PANoptosis
is
involved
in
the
interaction
of
apoptosis,
necroptosis
and
pyroptosis,
playing
a
role
programmed
cell
death.
Moreover,
long
non-coding
RNAs
(lncRNAs)
regulate
PCD.
This
work
aims
to
explore
PANoptosis-associated
lncRNAs
hepatocellular
carcinoma
(HCC).
Methods:
Co-expression
analysis
identified
HCC.
Cox
Least
Absolute
Shrinkage
Selection
Operator
(LASSO)
algorithms
were
utilised
filter
establish
PANoptosis-related
lncRNA
index
(PANRI).
Additionally,
Cox,
Kaplan–Meier
receiver
operating
characteristic
(ROC)
curves
systematically
evaluate
PANRI.
Furthermore,
Estimation
STromal
Immune
cells
MAlignant
Tumor
tissues
using
Expression
data
(ESTIMATE),
single
sample
gene
set
enrichment
(ssGSEA)
immune
checkpoints
performed
analyse
potential
PANRI
differentiating
different
tumour
microenvironment
(TIME)
populations.
The
consensus
clustering
algorithm
was
used
distinguish
individuals
with
HCC
having
TIME
subtypes.
Finally,
lines
HepG2
for
further
validation
vitro
experiments.
Results:
differentiates
patients
according
risk.
Notably,
ESTIMATE
ssGSEA
revealed
high
infiltration
status
high-risk
patients.
divided
into
three
clusters
identify
subtypes
TIME.
results
showed
that
siRNA-mediated
silencing
AL049840.4
inhibited
viability
migration
promoted
apoptosis.
Conclusions:
first
PANoptosis-related,
lncRNA-based
risk
assess
patient
prognosis,
response
immunotherapy.
study
offers
novel
perspectives
on
Frontiers in Immunology,
Год журнала:
2025,
Номер
16
Опубликована: Март 21, 2025
Background
The
SUSD3
protein,
marked
by
the
Sushi
domain,
plays
a
key
role
in
cancer
progression,
with
its
expression
linked
to
tumor
advancement
and
patient
prognosis.
Altered
levels
could
serve
as
predictive
biomarker
for
progression.
Recognized
novel
susceptibility
marker,
presents
promising
target
antibody-based
therapies,
offering
potential
approach
prevention,
diagnosis,
treatment
of
breast
cancer.
Methods
Using
HPA
GeneMANIA
platforms,
distribution
protein
across
tissues
was
analyzed,
while
healthy
were
compared
using
Cancer
Genome
Atlas
data.
TISCH
STOmics
DB
databases
facilitated
mapping
different
cell
types
spatial
relationship
markers.
Univariate
Cox
regression
assessed
prognostic
significance
various
cancers.
Genomic
alterations
explored
through
cBioPortal
database.
predictor
immunotherapy
response
investigated
TIMER2.0,
GSEA/GSVA
identified
related
biological
pathways.
Drugs
targeting
CellMiner,
CTRP,
GDSC
databases,
complemented
molecular
docking
studies.
In
vitro
experiments
demonstrated
that
knockdown
lines
significantly
reduced
proliferation
migration.
Results
variations
pan-cancer
cohorts
are
closely
prognosis
malignancies.
microenvironment
(TME),
is
predominantly
expressed
monocytes/macrophages
CD4+
T
cells.
Research
indicates
strong
correlation
between
biomarkers,
immune
infiltration,
immunomodulatory
factors.
To
explore
regulatory
role,
StromalScore,
ImmuneScore,
ESTIMATE,
Immune
Infiltration
metrics
employed.
Molecular
studies
revealed
selumetinib
inhibits
proliferation.
Finally,
Conclusion
These
findings
provide
valuable
insights
establish
foundation
further
exploration
SUSD3’s
pan-carcinomas.
Additionally,
they
offer
perspectives
targets
development
innovative
therapeutic
strategies
treatment.
Journal of Cellular and Molecular Medicine,
Год журнала:
2025,
Номер
29(8)
Опубликована: Апрель 1, 2025
ABSTRACT
GMIP,
a
member
of
the
RhoGAP
family,
plays
critical
role
in
cytoskeletal
remodelling,
cell
migration
and
immune
modulation.
Its
aberrant
expression
cancers
suggests
pivotal
tumour
progression.
GMIP
was
assessed
using
transcriptomic
datasets
from
GDC
UCSC
XENA,
protein
distribution
across
tissues
via
HPA
GeneMANIA.
The
TISCH
database
identified
primary
GMIP‐expressing
types
microenvironment.
Univariate
Cox
regression
GMIP's
prognostic
potential,
while
cBioPortal
GSCA
explored
genomic
alterations.
TIMER
2.0
used
to
investigate
infiltration
regulation.
GSEA
GSVA
unveiled
GMIP‐related
biological
pathways,
molecular
docking
with
CellMiner
potential
drug
interactions.
In
vitro
assays
confirmed
functional
relevance
breast
cancer.
exhibits
differential
multiple
cancer
types,
demonstrating
significant
implications.
is
inversely
correlated
CNV
methylation
several
cancers.
closely
linked
immunotherapy
biomarkers
suppression,
influencing
therapeutic
responses.
Functional
studies
suggest
that
inhibition
reduces
proliferation
migration.
as
promising
oncological
biomarker,
particularly
cancer,
especially
pronounced
BRCA‐mutated
tumours,
underscoring
its
for
novel
anticancer
interventions.
Biochemistry and Biophysics Reports,
Год журнала:
2023,
Номер
37, С. 101600 - 101600
Опубликована: Дек. 7, 2023
Cancer
growth
is
significantly
influenced
by
processes
such
as
pyroptosis,
apoptosis,
and
necroptosis
that
underlie
PANoptosis,
a
proinflammatory
programmed
cell
death.
Several
studies
have
examined
the
long
non-coding
RNAs
(lncRNAs)
associated
with
pancreatic
adenocarcinoma
(PAAD).
However,
predictive
value
of
lncRNAs
related
to
PANoptosis
for
PAAD
has
not
been
established.
PLoS ONE,
Год журнала:
2024,
Номер
19(4), С. e0298775 - e0298775
Опубликована: Апрель 25, 2024
Background
Activated
neutrophils
release
depolymerized
chromatin
and
protein
particles
into
the
extracellular
space,
forming
reticular
Neutrophil
Extracellular
Traps
(NETs).
This
process
is
accompanied
by
programmed
inflammatory
cell
death
of
neutrophils,
known
as
NETosis.
Previous
reports
have
demonstrated
that
NETosis
plays
a
significant
role
in
immune
resistance
microenvironmental
regulation
cancer.
study
sought
to
characterize
function
molecular
mechanism
NETosis-correlated
long
non-coding
RNAs
(NCLs)
prognostic
treatment
liver
hepatocellular
carcinoma
(LIHC).
Methods
We
obtained
transcriptomic
clinical
data
from
The
Cancer
Genome
Atlas
(TCGA)
evaluated
expression
NCLs
LIHC.
A
signature
was
constructed
using
Cox
Last
Absolute
Shrinkage
Selection
Operator
(Lasso)
regression,
while
accuracy
model
validated
ROC
curves
nomogram,
etc.
In
addition,
we
analyzed
associations
between
oncogenic
mutation,
infiltration
evasion.
Finally,
LIHC
patients
were
classified
four
subgroups
based
on
consensus
cluster
analysis,
drug
sensitivity
predicted.
Results
After
screening,
established
risk
combining
5
hub-NCLs
its
reliability.
Independence
checks
suggest
may
serve
an
independent
predictor
prognosis.
Enrichment
analysis
revealed
concentration
immune-related
pathways
high-risk
group.
Immune
indicates
immunotherapy
could
be
more
effective
low-risk
Upon
consistent
subgroup
4
presented
better
Sensitivity
tests
showed
distinctions
therapeutic
effectiveness
among
various
drugs
different
subgroups.
Conclusion
Overall,
developed
can
discriminate
through
selected
NCLs,
with
objective
providing
precise,
personalized
regimen.
Abstract
Background
Ion
channels
play
an
important
role
in
tumorigenesis
and
progression
of
cervical
cancer.
Multiple
long
non‐coding
RNA
genes
are
widely
involved
ion
channel‐related
signaling
regulation.
However,
the
association
potential
clinical
application
lncRNAs
prognosis
cancer
still
poorly
explored.
Methods
Thirteen
patients
with
were
enrolled
current
study.
Whole
transcriptome
(involving
both
mRNAs
lncRNAs)
sequencing
was
performed
on
fresh
tumor
adjacent
normal
tissues
that
surgically
resected
from
patients.
A
comprehensive
cancer‐specific
lncRNA
landscape
obtained
by
our
custom
pipeline.
Then,
a
prognostic
scoring
model
ion‐channel‐related
established
regression
algorithms.
The
performance
predictive
as
well
its
characteristics
microenvironment
(TME)
status
further
evaluated.
Results
To
comprehensively
identify
lncRNAs,
we
sequenced
26
samples
integrated
transcriptomic
results.
We
built
analysis
pipeline
to
improve
accuracy
identification
functional
annotation
18,482
novel
159
channel‐
tumorigenesis‐related
(ICTR‐)
identified.
Based
nine
ICTR‐lncRNAs,
also
validated
robustness
assessing
Besides,
TME
characterized,
found
B
cells,
activated
CD8+
T,
tertiary
lymphoid
structures
significantly
associated
ICTR‐lncRNAs
signature
scores.
Conclusion
provided
thorough
lncRNAs.
Through
integrative
analyses,
identified
for
Meanwhile,
characterized
status.
This
study
improved
knowledge
prominent
roles
regulating
channel
Cancer-associated
fibroblasts
(CAFs)
regulate
the
malignant
biological
behaviour
of
hepatocellular
carcinoma
(HCC)
as
a
significant
component
tumour
immune
microenvironment
(TIME).
This
study
aimed
to
develop
CAFs-based
scoring
system
predict
prognosis
and
TIME
patients
with
HCC.Data
for
TCGA-LIHC
GSE14520
cohorts
were
downloaded
from
The
Cancer
Genome
Atlas
Gene
Expression
Omnibus
databases.
Single-cell
RNA-sequencing
data
HCC
samples
retrieved
GSE166635
cohort.
Least
Absolute
Shrinkage
Selection
Operator
algorithm
was
employed
CAFs-related
(CAFRss).
predictive
value
CAFRss
determined
using
Kaplan-Meier,
Cox
regression
Receiver
Operating
Characteristic
curves.
Additionally,
TIMER
platform,
single
sample
Set
Enrichment
Analysis
Estimation
STromal
Immune
cells
in
MAlignant
Tumour
tissues
algorithms
performed
determine
landscape.
Finally,
pRRophic
utilised
drug
sensitivity
analysis.The
evaluation
demonstrated
its
superior
ability
clinical
outcome
HCC.
effectively
distinguished
populations
distinct
landscapes.
Furthermore,
CAFRss-based
risk
stratification
identified
individuals
'hot
tumours'
predicted
survival
treated
ICBs.The
developed
can
serve
tool
determining
differentiating
diverse
characteristics.
Medicine,
Год журнала:
2023,
Номер
102(50), С. e36611 - e36611
Опубликована: Дек. 15, 2023
The
objective
of
this
study
is
to
explore
the
relationship
between
cuproptosis-related
long
noncoding
RNAs
(lncRNAs)
in
hepatocellular
carcinoma
(HCC).
RNA-seq
data,
including
lncRNAs
and
related
clinical
information
HCC
patients,
were
downloaded
from
Cancer
Genome
Atlas
database.
A
signature
composed
3
was
constructed
by
LASSO
analysis,
patients
classified
into
high-
low-risk
groups.
Patients
high-risk
group
had
a
poorer
prognosis
compared
with
group.
Univariate
Cox
multivariate
regression
analyses
confirmed
that
model
an
independent
risk
factor
other
biomarkers.
Furthermore,
gene
set
enrichment
analysis
indicated
metabolism-related
pathways
enriched
group,
drug
metabolism,
fatty
acid
metabolism.
Further
research
demonstrated
there
markedly
differences
response
Immune
showed
most
type
immune
cells
immunological
function
different
risk-group.
Finally,
TP53
mutation
rate
tumor
mutational
burden
higher
In
conclusion,
we
prognostic
based
on
expression
predict
patients'
prognosis,
microenvironment,
further
will
be
conducted
uncover
mechanisms.
Aging,
Год журнала:
2024,
Номер
16(6), С. 5288 - 5310
Опубликована: Март 8, 2024
Introduction:
Regulatory
T
cells
(Tregs)
play
important
roles
in
tumor
immunosuppression
and
immune
escape.
The
aim
of
the
present
study
was
to
construct
a
novel
Tregs-associated
biomarker
for
prediction
tumour
microenvironment
(TIME),
clinical
outcomes,
individualised
treatment
hepatocellular
carcinoma
(HCC).
Methods:
Single-cell
sequencing
data
were
obtained
from
three
independent
cohorts.
Cox
LASSO
regression
utilised
develop
Tregs
Related
Scoring
System
(TRSSys).
GSE140520,
ICGC-LIRI
CHCC
cohorts
used
validation
TRSSys.
Kaplan-Meier,
ROC,
evaluation
ESTIMATE,
TIMER
2.0,
ssGSEA
algorithm
determine
value
TRSSys
predicting
TIME.
GSVA,
GO,
KEGG,
TMB
analyses
mechanistic
exploration.
Finally,
drug
sensitivity
evaluated
based
on
oncoPredict
algorithm.
pResults:
Comprehensive
showed
that
had
good
prognostic
predictive
efficacy
applicability.
Additionally,
ssGSEA,
ESTIMATE
suggested
could
help
distinguish
different
TIME
subtypes
beneficiary
population
immunotherapy.
suggests
provides
basis
treatment.
Conclusions:
constructed
current
is
HCC
with
stability.
risk
stratification
can
identify
landscape
provide
individualized
options.